Suanfarma Suanfarma

X

Find Halofantrine Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Halofantrine Hydrochloride
Also known as: 36167-63-2, Halfan, Halofantrine hcl, Halofantrine hydrochloride [usan], Wr-171669, Skf-102886
Molecular Formula
C26H31Cl3F3NO
Molecular Weight
536.9  g/mol
InChI Key
WANGFTDWOFGECH-UHFFFAOYSA-N
FDA UNII
H77DL0Y630

1 2D Structure

Halofantrine Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride
2.1.2 InChI
InChI=1S/C26H30Cl2F3NO.ClH/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23;/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3;1H
2.1.3 InChI Key
WANGFTDWOFGECH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O.Cl
2.2 Other Identifiers
2.2.1 UNII
H77DL0Y630
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol Hcl

2. Halfan

3. Halofantrine

4. Wr 171,699

5. Wr 171669

6. Wr-171,669

7. Wr-171699

2.3.2 Depositor-Supplied Synonyms

1. 36167-63-2

2. Halfan

3. Halofantrine Hcl

4. Halofantrine Hydrochloride [usan]

5. Wr-171669

6. Skf-102886

7. Halofantrine (hydrochloride)

8. 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride

9. (-)-halofantrine Hydrochloride

10. 2b7enl644k

11. 106927-11-1

12. Halofantrine Hydrochloride, (-)-

13. H77dl0y630

14. 3-(dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol Hydrochloride

15. 9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene Hydrochloride

16. Dl-wr 171669

17. Ncgc00016833-01

18. Skf-102886;wr-171669

19. Dsstox_cid_25464

20. Dsstox_rid_80895

21. Dsstox_gsid_45464

22. Halofantrine Hydrochloride (usan)

23. Halofantrino

24. Halofantrino [spanish]

25. Mls002154111

26. 66051-64-7

27. Cas-36167-63-2

28. (+-)-halofantrine Hydrochloride

29. Wr 171669

30. Wr-171,669

31. Smr001233418

32. Einecs 252-895-4

33. Unii-h77dl0y630

34. Halfan (tn)

35. Mfcd00879136

36. Skf 102886

37. Halofantrine Hydrochlorid

38. 1,3-dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene Hcl

39. 1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol Hydrochloride

40. Unii-2b7enl644k

41. 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol Hydrochloride

42. Schembl466895

43. Chembl1200901

44. Dtxsid0045464

45. Hy-a0148a

46. Hms1571o03

47. Tox21_110637

48. Akos030254762

49. Tox21_110637_1

50. Ccg-221031

51. Halofantrine Hydrochloride [mi]

52. Sk&f-102866

53. Ncgc00179250-03

54. (+/-)-halofantrine Hydrochloride

55. 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol Hydrochloride

56. 9-phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride

57. Halofantrine Hydrochloride [mart.]

58. Halofantrine Hydrochloride [vandf]

59. Halofantrine Hydrochloride [who-dd]

60. Cs-0031225

61. Ft-0600399

62. D02485

63. Halofantrine Hydrochloride [ep Impurity]

64. Halofantrine Hydrochloride [orange Book]

65. Halofantrine Hydrochloride [ep Monograph]

66. 167h632

67. Halofantrine Hydrochloride, >=98% (hplc), Solid

68. Sr-01000841216

69. Sr-01000841216-2

70. W-106636

71. Halofantrine Hydrochloride, European Pharmacopoeia (ep) Reference Standard

72. 1-[1,3-dichloro-6-trifluoromethyl-9-phenanthryl]-3-di(n-butyl)aminopropanol Hydrochloride

73. 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol Hydrochloride

74. 1,3-dichloro-alpha-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrenemethanol;(+/-)-halofantrine Hydrochloride

75. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride

76. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride (1:1)

77. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride, (-)-

78. 9-phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride, (-)-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 536.9 g/mol
Molecular Formula C26H31Cl3F3NO
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count10
Exact Mass535.142332 g/mol
Monoisotopic Mass535.142332 g/mol
Topological Polar Surface Area23.5 Ų
Heavy Atom Count34
Formal Charge0
Complexity584
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antimalarials

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY